Quentin Pankhurst
Directeur/Membre du Conseil chez The Royal Institution of Great Britain
Postes actifs de Quentin Pankhurst
| Sociétés | Poste | Début |
|---|---|---|
| University College London | Corporate Officer/Principal | 21/07/2011 |
| Davy-Faraday Research Laborator | Directeur/Membre du Conseil | 21/07/2011 |
The Royal Institution of Great Britain
 The Royal Institution of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Institution of Great Britain is a charitable organization that is dedicated to connecting people with the world of science. | Directeur/Membre du Conseil | 21/07/2011 |
Anciens postes connus de Quentin Pankhurst
| Sociétés | Poste | Fin |
|---|---|---|
| University of California, Los Angeles | Corporate Officer/Principal | - |
Endomagnetics Ltd.
 Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Fondateur | - |
Formation de Quentin Pankhurst
| The University of Liverpool | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
The Royal Institution of Great Britain
The Royal Institution of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Institution of Great Britain is a charitable organization that is dedicated to connecting people with the world of science. | Commercial Services |
Endomagnetics Ltd.
Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
| Davy-Faraday Research Laborator |
